炎症性肠病
免疫系统
肠上皮
肠道菌群
微生物群
生物
溃疡性结肠炎
免疫学
肠易激综合征
疾病
上皮
医学
遗传学
病理
生物信息学
胃肠病学
作者
Shruti Ahlawat,Pramod Kumar,Hari Mohan,Sandeep Goyal,Krishna Kant Sharma
标识
DOI:10.1080/1040841x.2021.1876631
摘要
Human gut microbiota contributes to host nutrition and metabolism, sustains intestinal cell proliferation and differentiation, and modulates host immune system. The alterations in their composition lead to severe gut disorders, including inflammatory bowel disease (IBD) or inflammatory bowel syndrome (IBS). IBD including ulcerative colitis (UC) and Crohn’s disease (CD) are gamut of chronic inflammatory disorders of gut, mediated by complex interrelations among genetic, environmental, and internal factors. IBD has debateable aetiology, however in recent years, exploring the central role of a tri-directional relationship between gut microbiota, mucosal immune system, and intestinal epithelium in pathogenesis is getting the most attention. Increasing incidences and early onset explains the exponential rise in IBD burden on health-care systems. Industrialization, hypersensitivity to allergens, lifestyle, hygiene hypothesis, loss of intestinal worms, and gut microbial composition, explains this shifted rise. Hitherto, the interventions modulating gut microbiota composition, microfluidics-based in vitro gastrointestinal models, non-allergic functional foods, nutraceuticals, and faecal microbiota transplantation (FMT) from healthy donors are some of the futuristic approaches for the disease management.
科研通智能强力驱动
Strongly Powered by AbleSci AI